Prot #NU 20G02: A Phase II Trial of Irinotecan Liposome and Bevacizumab in Women with Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date2/25/212/25/24

Funding

  • Ipsen Biopharmaceuticals, Inc. (Prot #NU 20G02)